{"id":"https://openalex.org/W4377823951","doi":"https://doi.org/10.1201/9781003423775-8","title":"Therapeutic applications of viral vectors","display_name":"Therapeutic applications of viral vectors","publication_year":2023,"publication_date":"2023-05-23","ids":{"openalex":"https://openalex.org/W4377823951","doi":"https://doi.org/10.1201/9781003423775-8"},"language":"en","primary_location":{"id":"doi:10.1201/9781003423775-8","doi":"https://doi.org/10.1201/9781003423775-8","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003423775-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463313","display_name":"Garland Science eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genetically Engineered Viruses","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4377824016","display_name":"Genetically Engineered Viruses"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080277287","display_name":"Pedro Ricardo Lowenstein","orcid":"https://orcid.org/0000-0002-8427-4409","observed_orcids":["https://orcid.org/0000-0002-8427-4409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro Lowenstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043254233","display_name":"Daniel Stone","orcid":"https://orcid.org/0000-0003-1619-7541","observed_orcids":["https://orcid.org/0000-0003-1619-7541","https://orcid.org/0000-0002-9861-8321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Stone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108268208","display_name":"Anne David","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne David","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069116024","display_name":"Alan A. Melcher","orcid":"https://orcid.org/0000-0002-2042-3380","observed_orcids":["https://orcid.org/0000-0002-2042-3380"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Melcher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070554485","display_name":"Richard G. Vile","orcid":"https://orcid.org/0000-0003-2192-9372","observed_orcids":["https://orcid.org/0000-0003-2192-9372"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Vile","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103382625","display_name":"Clare E. Thomas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clare Thomas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Dominique Bataille","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominique Bataille","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082380342","display_name":"Maria Graciela Castro","orcid":"https://orcid.org/0000-0003-2237-2756","observed_orcids":["https://orcid.org/0000-0003-2237-2756"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Castro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18663947,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"215","last_page":"254"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/viral-vectors","display_name":"viral vectors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/retroviral-vectors","display_name":"retroviral vectors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.8539999723434448},{"id":"https://openalex.org/keywords/adeno-associated-virus-vectors","display_name":"adeno-associated virus vectors","score":0.9129999876022339},{"id":"https://openalex.org/keywords/replication-competent-virus","display_name":"replication-competent virus","score":0.7429999709129333},{"id":"https://openalex.org/keywords/tumorigenicity","display_name":"tumorigenicity","score":0.7860000133514404},{"id":"https://openalex.org/keywords/vector-toxicity","display_name":"vector toxicity","score":0.609000027179718},{"id":"https://openalex.org/keywords/galactosyltransferase","display_name":"galactosyltransferase","score":0.75},{"id":"https://openalex.org/keywords/serum-resistance","display_name":"serum resistance","score":0.6579999923706055},{"id":"https://openalex.org/keywords/antibody-fragments","display_name":"antibody fragments","score":0.5270000100135803},{"id":"https://openalex.org/keywords/gene-transfer-efficiency","display_name":"gene transfer efficiency","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4770335853099823},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3360482156276703},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3180868327617645}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003423775-8","doi":"https://doi.org/10.1201/9781003423775-8","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003423775-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463313","display_name":"Garland Science eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genetically Engineered Viruses","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1494443925","https://openalex.org/W1706025319","https://openalex.org/W2413608033","https://openalex.org/W4211064366","https://openalex.org/W7063216935","https://openalex.org/W1983781699","https://openalex.org/W2396707069","https://openalex.org/W2035335384","https://openalex.org/W4243712646","https://openalex.org/W1974053780"],"abstract_inverted_index":{"To":[0],"some":[1],"extent":[2],"comparative":[3],"toxicity":[4],"will":[5],"depend":[6],"on":[7,61,104],"viral":[8],"doses":[9,28],"used":[10,24],"for":[11,110,116],"each":[12],"type":[13],"of":[14,66,100,124],"vector,":[15],"i.e.":[16],"usually":[17],"retroviral":[18,33,57,140],"vectors":[19,22,34,58,80,141],"and":[20,97],"AAV":[21],"are":[23,59,92],"at":[25],"much":[26],"lower":[27],"than":[29],"adenovirus":[30],"vectors.":[31],"Murine":[32],"contaminated":[35],"with":[36,73],"RCR":[37],"have":[38],"been":[39],"shown":[40],"to":[41,52,94,127,138,142],"be":[42,108],"tumorigenic":[43],"in":[44,82,111,136],"non-human":[45],"primates":[46],"raising":[47],"concerns":[48],"over":[49],"the":[50,55,64,98,122],"risk":[51],"humans.":[53],"As":[54],"current":[56],"based":[60,103],"murine":[62],"viruses":[63],"likelihood":[65],"producing":[67],"replication":[68],"competent":[69],"virus,":[70],"through":[71],"recombination":[72],"endogenous":[74],"human":[75,95],"retroviruses,":[76],"is":[77],"reduced.":[78],"Retroviral":[79],"generated":[81],"packaging":[83],"cell":[84,144],"lines,":[85],"which":[86],"do":[87],"not":[88],"express":[89,128],"an":[90],"galactosyltransferase,":[91],"resistant":[93],"serum":[96],"construction":[99],"vector":[101],"systems":[102],"these":[105],"retroviruses":[106],"would":[107],"advantageous":[109],"vivo":[112],"applications.":[113],"Alternative":[114],"strategies":[115],"increasing":[117],"gene":[118],"transfer":[119],"efficiency":[120],"include":[121],"modification":[123],"envelope":[125],"proteins":[126],"N-terminal":[129],"binding":[130],"domains":[131],"or":[132],"functional":[133],"antibody":[134],"fragments":[135],"order":[137],"target":[139],"specific":[143],"types.":[145]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2023-05-24T00:00:00"}
